Research and Markets: Global Herpes Simplex Infections Therapeutics Pipeline Review, H2 2015

Research and Markets (http://www.researchandmarkets.com/research/d34n87/herpes_simplex) has announced the addition of the "Herpes Simplex Infections - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Simplex Infections and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • 3-V Biosciences, Inc.
  • Adamis Pharmaceuticals Corporation
  • Admedus Ltd
  • AiCuris GmbH & Co. KG
  • Astellas Pharma Inc.
  • Beech Tree Labs, Inc.
  • CEL-SCI Corporation
  • Chimerix, Inc.
  • Epiphany Biosciences, Inc.
  • Foamix Pharmaceuticals Ltd.
  • Genocea Biosciences, Inc.
  • GenVec, Inc.
  • Immune Design Corp.
  • Immunovaccine, Inc.
  • JN-International Medical Corporation
  • Microbiotix, Inc.
  • Mymetics Corporation
  • NanoBio Corporation
  • NanoViricides, Inc.
  • Onxeo SA
  • Oryzon Genomics S.A.
  • Osel Inc.
  • PaxVax
  • Peregrine Pharmaceuticals, Inc.
  • Profectus BioSciences, Inc.
  • Romark Laboratories, L.C.
  • Sanofi
  • Sanofi Pasteur SA
  • Shulov Innovative Science Ltd.
  • Spider Biotech
  • Starpharma Holdings Limited
  • Vaccibody AS
  • Vaxart, Inc.
  • Vical Incorporated
  • Vironova AB

For more information visit http://www.researchandmarkets.com/research/d34n87/herpes_simplex

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.